title: Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naïve HIV-2-infected patient.
authors.affiliation: aCRP-Santé, Laboratory of Retrovirology bCRP-Santé, Laboratory of Cellular and Molecular Oncology cCentre Hospitalier de Luxembourg, Department of Infectious Diseases, Luxembourg City, Luxembourg.
authors.forename: Yue
authors.initials: Y
authors.lastname: Zheng
authors.forename: Christine
authors.initials: C
authors.lastname: Lambert
authors.forename: Vic
authors.initials: V
authors.lastname: Arendt
authors.forename: Carole
authors.initials: C
authors.lastname: Seguin-Devaux
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015498:HIV-2 / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015363:Quinolones / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D015363:Quinolones; C509700:elvitegravir